(666154, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010570', 'prolonged ST segment', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666155, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666156, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001863', 'blood vessel inflammation', 0.40540540540540543, 8.605269980670606, 1.8677855779335946, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666157, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666158, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666159, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010509', 'decreased P wave amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666160, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0005140', 'decreased cardiac muscle contractility', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666161, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666162, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666163, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0011938', 'prolonged PP interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666164, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666165, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666166, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666167, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666168, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0020346', 'abnormal myocardial fiber calcium currents', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666169, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0002498', 'abnormal acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666170, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666171, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666172, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666173, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0020154', 'impaired humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666174, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666175, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0006053', 'hypothalamus hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666176, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003898', 'abnormal QRS complex', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666177, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666178, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0011514', 'skin hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666179, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0000304', 'abnormal cardiac stroke volume', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666180, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0006114', 'cardiac murmur', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666181, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001790', 'abnormal immune system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666182, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666183, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666184, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666185, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004072', 'abnormal frontal plane axis', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666186, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003037', 'increased myocardial infarct size', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666187, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0011929', 'abnormal aortic valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666188, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666189, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004012', 'increased pulmonary artery pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666190, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004217', 'salt-sensitive hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666191, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666192, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0008950', 'ventricular tachycardia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666193, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666194, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666195, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0005591', 'decreased vasodilation', 0.40540540540540543, 8.605269980670606, 1.8677855779335946, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666196, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004485', 'increased response of heart to induced stress', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666197, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666198, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666199, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003438', 'abnormal carotid body physiology', 0.4838709677419355, 8.605269980670606, 2.0405490225004916, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666200, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0006046', 'atrioventricular valve regurgitation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666201, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666202, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666203, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001845', 'abnormal inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666204, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003549', 'pulmonary hypotension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666205, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666206, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666207, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0008775', 'abnormal heart ventricle pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666208, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666209, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010631', 'increased Q wave amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666210, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666211, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666212, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666213, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666214, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0002626', 'increased heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666215, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010520', 'sinoatrial block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666216, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666217, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666218, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666219, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666220, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666221, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666222, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666223, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666224, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666225, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666226, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010559', 'heart block', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666227, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0011937', 'shortened PP interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666228, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666229, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666230, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666231, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0020347', 'abnormal myocardial fiber sodium currents', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666232, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0005167', 'abnormal blood-brain barrier function', 0.42857142857142855, 8.605269980670606, 1.9204095523764797, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666233, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666234, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010504', 'abnormal RR interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666235, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004013', 'decreased pulmonary artery pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666236, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666237, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666238, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666239, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004071', 'prolonged P wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666240, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004122', 'abnormal sinus arrhythmia', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666241, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666242, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666243, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004070', 'abnormal P wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666244, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666245, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666246, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0006048', 'pulmonary valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666247, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003393', 'decreased cardiac output', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666248, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0005000', 'abnormal immune tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666249, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010554', 'shortened HV interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666250, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666251, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010506', 'prolonged RR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666252, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0012046', 'decreased susceptibility to hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666253, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0020418', 'increased cardiac muscle relaxation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666254, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666255, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0006266', 'decreased pulse pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666256, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004879', 'decreased systemic vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666257, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666258, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0031154', 'intestinal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666259, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666260, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0009275', 'bruising', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666261, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666262, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0031170', 'abnormal vasculature physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666263, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0011952', 'decreased cardiac stroke volume', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666264, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010515', 'abnormal Q wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666265, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0031192', 'coronary artery spasm', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666266, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0011928', 'abnormal mitral valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666267, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0011925', 'abnormal heart echocardiography feature', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666268, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004752', 'decreased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666269, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001613', 'abnormal vasodilation', 0.4166666666666667, 8.605269980670606, 1.8935493546809792, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666270, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004484', 'abnormal response of heart to induced stress', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666271, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666272, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0005025', 'abnormal response to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666273, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010552', 'abnormal HV interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666274, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003071', 'decreased vascular permeability', 0.40540540540540543, 8.605269980670606, 1.8677855779335946, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666275, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666276, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666277, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666278, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666279, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666280, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666281, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666282, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0020317', 'abnormal vascular endothelial cell adhesion', 0.40540540540540543, 8.605269980670606, 1.8677855779335946, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666283, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003896', 'prolonged PR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666284, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666285, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666286, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666287, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666288, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0012045', 'increased susceptibility to hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666289, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666290, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0005595', 'abnormal vascular smooth muscle physiology', 0.42857142857142855, 8.605269980670606, 1.9204095523764797, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666291, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010513', 'abnormal ventricular activation time', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666292, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010511', 'shortened PR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666293, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001619', 'abnormal vascular permeability', 0.4166666666666667, 8.605269980670606, 1.8935493546809792, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666294, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666295, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666296, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666297, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666298, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0013127', 'epistaxis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666299, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666300, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004878', 'increased systemic vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666301, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666302, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666303, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666304, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666305, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0005005', 'abnormal self tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666306, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0006088', 'abnormal blood-cerebrospinal fluid barrier function', 0.42857142857142855, 8.605269980670606, 1.9204095523764797, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666307, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666308, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666309, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666310, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666311, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0006052', 'cerebellum hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666312, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0011919', 'abnormal R wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666313, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666314, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666315, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003762', 'abnormal immune organ physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666316, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010756', 'decreased right ventricle peak pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666317, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0011926', 'abnormal heart valve physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666318, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001914', 'hemorrhage', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666319, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004216', 'salt-resistant hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666320, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666321, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0004011', 'decreased diastolic filling velocity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666322, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666323, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0006109', 'fibrillation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666324, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666325, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666326, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666327, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666328, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666329, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0003897', 'abnormal ST segment', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666330, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010637', 'sinus bradycardia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666331, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0031117', 'subdural hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666332, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0010505', 'abnormal T wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666333, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666334, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0013134', 'poor circulation in autopods', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666335, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001627', 'abnormal cardiac output', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666336, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(666337, 'HP:0030163', 'Abnormal vascular physiology', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666338, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030276', 'anterior cranium occultum', 0.40816326530612246, 7.821422361825214, 1.7867336932349218, 'UPHENO:0087814', 'abnormal cranium morphology'),
(666339, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030316', 'enlarged neurocranium', 0.4444444444444444, 8.373527591151573, 1.9291365473417343, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(666340, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030265', 'parietal bossing', 0.41509433962264153, 10.450642782231284, 2.082787234530311, 'UPHENO:0002700', 'abnormal vault of skull'),
(666341, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0010029', 'abnormal basicranium morphology', 0.4117647058823529, 8.373527591151573, 1.8568584021858787, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(666342, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030279', 'thin neurocranium', 0.43636363636363634, 8.373527591151573, 1.9115184929438012, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(666343, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030119', 'abnormal retrotympanic process morphology', 0.4074074074074074, 10.450642782231284, 2.0634120484405876, 'UPHENO:0002700', 'abnormal vault of skull'),
(666344, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0005272', 'abnormal temporal bone morphology', 0.4117647058823529, 8.373527591151573, 1.8568584021858787, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(666345, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0005269', 'abnormal occipital bone morphology', 0.44, 12.700256672302759, 2.36391897826749, 'UPHENO:0081587', 'abnormal occipital bone morphology'),
(666346, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0004385', 'interparietal bone hypoplasia', 0.4032258064516129, 10.450642782231284, 2.052795377967063, 'UPHENO:0002700', 'abnormal vault of skull'),
(666347, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0004441', 'small occipital bone', 0.45454545454545453, 12.700256672302759, 2.402674331230889, 'UPHENO:0081587', 'abnormal occipital bone morphology'),
(666348, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0000438', 'abnormal cranium morphology', 0.4166666666666667, 7.821422361825214, 1.8052495628288736, 'UPHENO:0087814', 'abnormal cranium morphology'),
(666349, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0009782', 'abnormal basicranium angle', 0.40384615384615385, 8.373527591151573, 1.8389173205479392, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(666350, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0000109', 'abnormal parietal bone morphology', 0.43137254901960786, 10.450642782231284, 2.1232334812414004, 'UPHENO:0002700', 'abnormal vault of skull'),
(666351, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030121', 'small temporal bone squamous part', 0.43103448275862066, 10.450642782231284, 2.1224013301291946, 'UPHENO:0002700', 'abnormal vault of skull'),
(666352, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0010031', 'abnormal cranium size', 0.45098039215686275, 7.821422361825214, 1.878112915657733, 'UPHENO:0087814', 'abnormal cranium morphology'),
(666353, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0000077', 'abnormal interparietal bone morphology', 0.43137254901960786, 10.450642782231284, 2.1232334812414004, 'UPHENO:0002700', 'abnormal vault of skull'),
(666354, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0005352', 'small cranium', 0.41818181818181815, 7.821422361825214, 1.8085288562906587, 'UPHENO:0087814', 'abnormal cranium morphology'),
(666355, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030287', 'enlarged occipital bone', 0.45454545454545453, 12.700256672302759, 2.402674331230889, 'UPHENO:0081587', 'abnormal occipital bone morphology'),
(666356, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0004418', 'small parietal bone', 0.43859649122807015, 10.450642782231284, 2.14093793823282, 'UPHENO:0002700', 'abnormal vault of skull'),
(666357, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0000078', 'abnormal supraoccipital bone morphology', 0.4230769230769231, 12.700256672302759, 2.3180132689881248, 'UPHENO:0081587', 'abnormal occipital bone morphology'),
(666358, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0000082', 'overlapping parietal bones', 0.41509433962264153, 10.450642782231284, 2.082787234530311, 'UPHENO:0002700', 'abnormal vault of skull'),
(666359, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0000919', 'cranioschisis', 0.4423076923076923, 7.821422361825214, 1.859966471585628, 'UPHENO:0087814', 'abnormal cranium morphology'),
(666360, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030288', 'broad occipital bone', 0.423728813559322, 12.700256672302759, 2.3197984161676013, 'UPHENO:0081587', 'abnormal occipital bone morphology'),
(666361, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0008818', 'abnormal interfrontal bone morphology', 0.41379310344827586, 8.373527591151573, 1.8614263264369006, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(666362, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0004444', 'small supraoccipital bone', 0.43859649122807015, 12.700256672302759, 2.3601457612121917, 'UPHENO:0081587', 'abnormal occipital bone morphology'),
(666363, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030286', 'occipital bone hypoplasia', 0.4098360655737705, 12.700256672302759, 2.2814519995725506, 'UPHENO:0081587', 'abnormal occipital bone morphology'),
(666364, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0000079', 'abnormal basioccipital bone morphology', 0.4074074074074074, 12.700256672302759, 2.2746820974086672, 'UPHENO:0081587', 'abnormal occipital bone morphology'),
(666365, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030282', 'broad supraoccipital bone', 0.423728813559322, 12.700256672302759, 2.3197984161676013, 'UPHENO:0081587', 'abnormal occipital bone morphology'),
(666366, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030420', 'short basicranium', 0.4067796610169492, 8.373527591151573, 1.8455841121565573, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(666367, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0004422', 'small temporal bone', 0.42857142857142855, 8.373527591151573, 1.8943744830212697, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(666368, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030225', 'abnormal cranial vertex morphology', 0.40816326530612246, 7.821422361825214, 1.7867336932349218, 'UPHENO:0087814', 'abnormal cranium morphology'),
(666369, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0004386', 'enlarged interparietal bone', 0.44642857142857145, 10.450642782231284, 2.1599688719474233, 'UPHENO:0002700', 'abnormal vault of skull'),
(666370, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0004442', 'occipital bone foramen', 0.46296296296296297, 12.700256672302759, 2.4248192632440517, 'UPHENO:0081587', 'abnormal occipital bone morphology'),
(666371, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0004423', 'abnormal temporal bone squamous part morphology', 0.41509433962264153, 10.450642782231284, 2.082787234530311, 'UPHENO:0002700', 'abnormal vault of skull'),
(666372, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0000080', 'abnormal exoccipital bone morphology', 0.4230769230769231, 12.700256672302759, 2.3180132689881248, 'UPHENO:0081587', 'abnormal occipital bone morphology'),
(666373, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030077', 'small cranial cavity', 0.41818181818181815, 7.821422361825214, 1.8085288562906587, 'UPHENO:0087814', 'abnormal cranium morphology'),
(666374, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0004446', 'split exoccipital bone', 0.4166666666666667, 12.700256672302759, 2.300385535830784, 'UPHENO:0081587', 'abnormal occipital bone morphology'),
(666375, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0004445', 'small exoccipital bone', 0.43859649122807015, 12.700256672302759, 2.3601457612121917, 'UPHENO:0081587', 'abnormal occipital bone morphology'),
(666376, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0004447', 'small basioccipital bone', 0.423728813559322, 12.700256672302759, 2.3197984161676013, 'UPHENO:0081587', 'abnormal occipital bone morphology'),
(666377, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030263', 'cranial bossing', 0.40816326530612246, 7.821422361825214, 1.7867336932349218, 'UPHENO:0087814', 'abnormal cranium morphology'),
(666378, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030264', 'occipital bossing', 0.4230769230769231, 12.700256672302759, 2.3180132689881248, 'UPHENO:0081587', 'abnormal occipital bone morphology'),
(666379, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030280', 'short parietal bone', 0.4032258064516129, 10.450642782231284, 2.052795377967063, 'UPHENO:0002700', 'abnormal vault of skull'),
(666380, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0000439', 'enlarged cranium', 0.41818181818181815, 7.821422361825214, 1.8085288562906587, 'UPHENO:0087814', 'abnormal cranium morphology'),
(666381, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0030315', 'small neurocranium', 0.4444444444444444, 8.373527591151573, 1.9291365473417343, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(666382, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0004421', 'enlarged parietal bone', 0.43859649122807015, 10.450642782231284, 2.14093793823282, 'UPHENO:0002700', 'abnormal vault of skull'),
(666383, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0000074', 'abnormal neurocranium morphology', 0.42857142857142855, 8.373527591151573, 1.8943744830212697, 'UPHENO:0088115', 'abnormal neurocranium morphology'),
(666384, 'HP:0012294', 'Abnormal occipital bone morphology', 'MP:0004384', 'small interparietal bone', 0.44642857142857145, 10.450642782231284, 2.1599688719474233, 'UPHENO:0002700', 'abnormal vault of skull'),
(666385, 'HP:0025444', 'Reduced amygdala volume', 'MP:0020530', 'disorganized thalamus', 0.4222222222222222, 7.13344151829186, 1.7354819301696724, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(666386, 'HP:0025444', 'Reduced amygdala volume', 'MP:0020525', 'abnormal thalamus size', 0.4222222222222222, 7.13344151829186, 1.7354819301696724, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(666387, 'HP:0025444', 'Reduced amygdala volume', 'MP:0012138', 'decreased forebrain size', 0.4166666666666667, 9.371930806217245, 1.9760999896911051, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(666388, 'HP:0025444', 'Reduced amygdala volume', 'MP:0000771', 'abnormal brain size', 0.4358974358974359, 6.213399309526074, 1.645723192772501, 'UPHENO:0076805', 'abnormal brain morphology'),
(666389, 'HP:0025444', 'Reduced amygdala volume', 'MP:0000783', 'abnormal forebrain morphology', 0.40540540540540543, 7.13344151829186, 1.7005692431238613, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(666390, 'HP:0025444', 'Reduced amygdala volume', 'MP:0012139', 'increased forebrain size', 0.4166666666666667, 9.371930806217245, 1.9760999896911051, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(666391, 'HP:0025444', 'Reduced amygdala volume', 'MP:0013229', 'abnormal brain ventricle size', 0.4186046511627907, 6.72807461644252, 1.6782143271385654, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(666392, 'HP:0025444', 'Reduced amygdala volume', 'MP:0012262', 'abnormal hindbrain size', 0.4090909090909091, 6.72807461644252, 1.6590341049152486, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(666393, 'HP:0025444', 'Reduced amygdala volume', 'MP:0012137', 'abnormal forebrain size', 0.47619047619047616, 9.371930806217245, 2.112539749551895, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(666394, 'HP:0025444', 'Reduced amygdala volume', 'MP:0004166', 'abnormal limbic system morphology', 0.42105263157894735, 9.821422361825213, 2.033552490420355, 'UPHENO:0086740', 'abnormal limbic system morphology'),
(666395, 'HP:0025444', 'Reduced amygdala volume', 'MP:0000831', 'diencephalon hyperplasia', 0.41304347826086957, 7.13344151829186, 1.7165143450276692, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(666396, 'HP:0025444', 'Reduced amygdala volume', 'MP:0000791', 'delaminated cerebral cortex', 0.41304347826086957, 7.13344151829186, 1.7165143450276692, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(666397, 'HP:0025444', 'Reduced amygdala volume', 'MP:0012775', 'abnormal brain weight', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(666398, 'HP:0025444', 'Reduced amygdala volume', 'MP:0030014', 'calcified brain', 0.4358974358974359, 6.213399309526074, 1.645723192772501, 'UPHENO:0076805', 'abnormal brain morphology'),
(666399, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666400, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666401, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666402, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666403, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666404, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666405, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666406, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666407, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666408, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666409, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666410, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666411, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666412, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666413, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666414, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666415, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666416, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666417, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666418, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666419, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666420, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666421, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666422, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666423, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666424, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666425, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666426, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666427, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666428, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666429, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666430, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666431, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666432, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666433, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666434, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666435, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666436, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666437, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666438, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666439, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666440, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666441, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666442, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666443, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666444, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666445, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666446, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666447, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666448, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666449, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666450, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666451, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666452, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666453, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666454, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666455, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666456, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666457, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666458, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666459, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666460, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666461, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666462, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666463, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666464, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666465, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666466, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666467, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666468, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666469, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666470, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666471, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666472, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666473, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666474, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666475, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666476, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666477, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666478, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666479, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666480, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666481, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666482, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666483, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666484, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666485, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666486, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666487, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666488, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666489, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666490, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666491, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666492, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666493, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666494, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666495, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666496, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666497, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666498, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666499, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666500, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666501, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666502, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666503, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666504, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666505, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666506, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666507, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666508, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666509, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666510, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666511, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666512, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666513, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666514, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666515, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666516, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666517, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666518, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666519, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666520, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666521, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666522, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666523, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666524, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666525, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666526, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666527, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666528, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666529, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666530, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666531, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666532, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666533, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666534, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666535, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666536, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666537, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666538, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666539, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666540, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666541, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666542, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666543, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666544, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666545, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666546, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666547, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666548, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666549, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666550, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666551, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666552, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666553, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666554, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666555, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666556, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666557, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666558, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666559, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666560, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666561, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666562, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666563, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666564, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666565, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666566, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666567, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666568, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666569, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666570, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666571, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666572, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666573, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666574, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666575, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666576, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666577, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666578, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666579, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666580, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666581, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666582, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666583, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666584, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666585, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666586, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666587, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666588, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666589, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666590, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666591, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666592, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666593, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666594, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666595, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666596, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666597, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666598, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666599, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666600, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666601, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666602, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666603, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666604, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666605, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666606, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666607, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666608, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666609, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666610, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666611, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666612, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666613, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666614, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666615, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666616, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666617, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666618, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666619, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666620, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666621, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666622, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666623, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666624, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666625, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666626, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666627, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666628, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666629, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666630, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666631, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666632, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666633, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666634, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666635, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666636, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666637, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666638, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666639, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666640, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666641, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666642, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666643, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666644, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666645, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666646, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666647, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666648, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666649, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666650, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666651, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666652, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666653, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666654, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666655, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666656, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666657, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666658, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666659, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666660, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666661, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666662, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666663, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666664, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666665, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666666, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666667, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666668, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666669, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666670, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666671, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666672, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666673, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666674, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666675, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666676, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666677, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666678, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666679, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666680, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666681, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666682, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666683, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666684, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666685, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666686, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666687, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666688, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666689, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666690, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666691, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666692, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666693, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666694, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666695, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666696, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666697, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666698, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666699, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666700, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666701, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666702, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666703, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666704, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666705, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666706, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666707, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666708, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666709, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666710, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666711, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666712, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666713, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666714, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666715, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666716, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666717, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666718, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666719, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666720, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666721, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666722, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666723, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666724, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666725, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666726, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666727, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666728, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666729, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666730, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666731, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666732, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666733, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666734, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666735, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666736, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666737, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666738, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666739, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666740, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666741, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666742, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666743, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666744, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666745, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666746, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666747, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666748, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666749, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666750, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666751, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666752, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666753, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666754, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666755, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666756, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666757, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666758, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666759, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666760, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666761, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666762, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666763, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666764, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666765, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666766, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666767, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666768, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666769, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666770, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666771, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666772, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666773, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666774, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666775, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666776, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666777, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666778, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666779, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666780, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666781, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666782, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666783, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666784, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666785, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666786, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666787, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666788, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666789, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666790, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666791, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666792, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666793, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666794, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666795, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666796, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666797, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666798, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666799, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666800, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666801, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666802, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666803, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666804, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666805, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666806, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666807, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666808, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666809, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666810, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666811, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666812, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666813, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666814, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666815, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666816, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666817, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666818, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666819, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666820, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666821, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666822, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666823, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666824, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666825, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666826, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666827, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666828, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666829, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666830, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666831, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666832, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666833, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666834, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666835, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666836, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666837, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666838, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666839, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666840, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666841, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666842, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666843, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666844, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666845, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666846, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666847, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666848, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666849, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666850, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666851, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666852, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666853, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666854, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666855, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666856, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666857, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666858, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666859, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666860, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666861, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666862, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666863, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666864, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666865, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666866, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666867, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666868, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666869, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666870, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666871, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666872, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666873, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666874, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666875, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666876, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666877, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666878, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666879, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666880, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666881, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666882, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666883, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666884, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666885, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666886, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666887, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666888, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666889, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666890, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666891, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666892, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666893, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666894, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666895, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666896, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666897, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666898, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666899, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666900, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666901, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666902, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666903, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666904, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666905, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666906, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666907, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666908, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666909, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666910, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666911, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666912, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666913, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666914, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666915, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666916, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666917, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666918, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666919, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666920, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666921, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666922, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666923, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666924, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666925, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666926, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666927, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666928, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666929, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666930, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666931, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666932, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666933, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666934, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666935, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666936, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666937, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666938, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666939, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666940, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666941, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666942, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666943, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666944, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666945, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666946, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666947, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666948, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666949, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666950, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666951, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666952, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666953, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666954, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666955, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666956, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666957, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666958, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666959, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666960, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666961, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666962, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666963, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666964, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666965, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666966, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666967, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666968, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666969, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666970, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666971, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666972, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666973, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666974, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666975, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666976, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666977, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666978, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666979, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666980, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666981, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666982, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666983, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666984, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666985, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666986, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666987, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666988, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666989, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666990, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666991, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666992, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666993, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666994, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666995, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666996, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666997, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(666998, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(666999, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667000, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667001, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667002, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667003, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667004, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667005, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667006, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667007, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667008, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667009, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667010, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667011, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667012, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667013, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667014, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667015, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667016, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667017, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667018, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667019, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667020, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667021, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667022, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667023, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667024, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667025, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667026, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667027, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667028, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667029, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667030, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667031, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667032, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667033, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667034, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667035, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667036, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667037, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667038, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667039, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667040, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667041, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667042, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667043, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667044, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667045, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667046, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667047, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667048, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667049, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667050, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667051, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667052, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667053, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667054, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667055, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667056, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667057, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667058, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667059, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667060, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667061, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667062, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667063, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667064, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667065, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667066, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667067, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667068, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667069, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667070, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667071, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667072, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667073, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667074, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667075, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667076, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667077, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667078, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667079, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667080, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667081, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667082, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667083, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667084, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667085, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667086, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667087, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667088, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667089, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667090, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667091, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667092, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667093, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667094, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667095, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667096, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667097, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667098, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667099, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667100, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667101, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667102, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667103, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667104, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667105, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667106, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667107, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667108, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667109, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667110, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667111, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667112, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667113, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667114, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667115, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667116, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667117, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667118, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667119, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667120, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667121, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667122, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667123, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667124, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667125, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667126, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667127, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667128, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667129, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667130, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667131, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667132, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667133, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667134, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667135, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667136, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667137, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667138, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667139, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667140, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667141, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667142, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667143, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667144, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667145, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667146, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667147, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667148, 'HP:0033395', 'Antilactoferrin antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667149, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003467', 'abnormal single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667150, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002064', 'seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667151, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667152, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001876', 'decreased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667153, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667154, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667155, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667156, 'HP:0011343', 'Moderate global developmental delay', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667157, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667158, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667159, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003472', 'increased summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667160, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000948', 'nonconvulsive seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667161, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667162, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667163, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667164, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667165, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002195', 'psychomotor seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667166, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667167, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667168, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003219', 'increased spike-wave discharge type II', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667169, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667170, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003009', 'abnormal cytokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667171, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667172, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667173, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667174, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667175, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003476', 'decreased summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667176, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667177, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001499', 'abnormal kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667178, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667179, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667180, 'HP:0011343', 'Moderate global developmental delay', 'MP:0014252', 'abnormal paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667181, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667182, 'HP:0011343', 'Moderate global developmental delay', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667183, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003008', 'enhanced long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667184, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667185, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003469', 'decreased single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667186, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667187, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667188, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667189, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667190, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667191, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020424', 'increased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667192, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008840', 'abnormal spike wave discharge', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667193, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667194, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667195, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001846', 'increased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667196, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667197, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667198, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667199, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667200, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667201, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667202, 'HP:0011343', 'Moderate global developmental delay', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667203, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667204, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667205, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667206, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004835', 'abnormal miniature endplate potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667207, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003485', 'abnormal channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667208, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667209, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667210, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667211, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667212, 'HP:0011343', 'Moderate global developmental delay', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667213, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002420', 'abnormal adaptive immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667214, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667215, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667216, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667217, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667218, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667219, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667220, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667221, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667222, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667223, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667224, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003473', 'decreased summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667225, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011397', 'endoneurial edema', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667226, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003216', 'absence seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667227, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667228, 'HP:0011343', 'Moderate global developmental delay', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667229, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001835', 'abnormal antigen presentation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667230, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667231, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004859', 'abnormal synaptic plasticity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667232, 'HP:0011343', 'Moderate global developmental delay', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667233, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667234, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667235, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667236, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667237, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667238, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667239, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667240, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667241, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667242, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667243, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667244, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003464', 'abnormal single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667245, 'HP:0011343', 'Moderate global developmental delay', 'MP:0030990', 'nerve inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667246, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667247, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002914', 'abnormal endplate potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667248, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667249, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667250, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667251, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667252, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003487', 'increased channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667253, 'HP:0011343', 'Moderate global developmental delay', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667254, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667255, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008921', 'increased neurotransmitter release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667256, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667257, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667258, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667259, 'HP:0011343', 'Moderate global developmental delay', 'MP:0009967', 'abnormal neuron proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667260, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006053', 'hypothalamus hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667261, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031109', 'subarachnoid hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667262, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667263, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667264, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667265, 'HP:0011343', 'Moderate global developmental delay', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667266, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667267, 'HP:0011343', 'Moderate global developmental delay', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667268, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667269, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003202', 'abnormal neuron apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667270, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667271, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667272, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667273, 'HP:0011343', 'Moderate global developmental delay', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667274, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667275, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667276, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667277, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667278, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667279, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667280, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667281, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003996', 'clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667282, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667283, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006060', 'increased cerebral infarct size', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667284, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667285, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667286, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002916', 'increased synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667287, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667288, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667289, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001473', 'reduced long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667290, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667291, 'HP:0011343', 'Moderate global developmental delay', 'MP:0021015', 'increased tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667292, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667293, 'HP:0011343', 'Moderate global developmental delay', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667294, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003990', 'decreased neurotransmitter release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667295, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667296, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667297, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667298, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667299, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667300, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000951', 'sporadic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667301, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667302, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667303, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667304, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002193', 'minimal clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667305, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002923', 'increased post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667306, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667307, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667308, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020000', 'abnormal response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667309, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667310, 'HP:0011343', 'Moderate global developmental delay', 'MP:0009141', 'increased prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667311, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667312, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667313, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667314, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020155', 'enhanced humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667315, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667316, 'HP:0011343', 'Moderate global developmental delay', 'MP:0021001', 'impaired neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667317, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667318, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003489', 'increased channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667319, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002419', 'abnormal innate immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667320, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667321, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003474', 'abnormal summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667322, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020154', 'impaired humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667323, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001475', 'reduced long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667324, 'HP:0011343', 'Moderate global developmental delay', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667325, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006080', 'brain ischemia', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667326, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003880', 'abnormal central pattern generator function', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667327, 'HP:0011343', 'Moderate global developmental delay', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667328, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667329, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667330, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667331, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667332, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667333, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667334, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667335, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003468', 'increased single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667336, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667337, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008814', 'decreased nerve conduction velocity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667338, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667339, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667340, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002207', 'abnormal long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667341, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003463', 'abnormal single cell response', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667342, 'HP:0011343', 'Moderate global developmental delay', 'MP:0014255', 'increased paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667343, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667344, 'HP:0011343', 'Moderate global developmental delay', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667345, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003889', 'enhanced sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667346, 'HP:0011343', 'Moderate global developmental delay', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667347, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001915', 'intracranial hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667348, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667349, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001916', 'intracerebral hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667350, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005004', 'abnormal lymphocyte anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667351, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667352, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667353, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667354, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667355, 'HP:0011343', 'Moderate global developmental delay', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667356, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667357, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667358, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667359, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003477', 'abnormal nerve fiber response', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667360, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667361, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005025', 'abnormal response to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667362, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001800', 'abnormal humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667363, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667364, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005671', 'abnormal response to transplant', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667365, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005000', 'abnormal immune tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667366, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667367, 'HP:0011343', 'Moderate global developmental delay', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667368, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667369, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667370, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012006', 'abnormal hippocampus physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667371, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004751', 'increased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667372, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002915', 'abnormal synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667373, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667374, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667375, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667376, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667377, 'HP:0011343', 'Moderate global developmental delay', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667378, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667379, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006051', 'brainstem hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667380, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003635', 'abnormal synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667381, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667382, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003475', 'increased summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667383, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667384, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667385, 'HP:0011343', 'Moderate global developmental delay', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667386, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667387, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667388, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667389, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006052', 'cerebellum hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667390, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003466', 'decreased single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667391, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003480', 'increased nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667392, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667393, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667394, 'HP:0011343', 'Moderate global developmental delay', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667395, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003465', 'increased single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667396, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667397, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667398, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667399, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667400, 'HP:0011343', 'Moderate global developmental delay', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667401, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667402, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000920', 'abnormal myelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667403, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667404, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667405, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667406, 'HP:0011343', 'Moderate global developmental delay', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667407, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667408, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031117', 'subdural hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667409, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004994', 'abnormal brain wave pattern', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667410, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002634', 'abnormal sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667411, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667412, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667413, 'HP:0011343', 'Moderate global developmental delay', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667414, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667415, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667416, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667417, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667418, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667419, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667420, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667421, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667422, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001500', 'decreased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667423, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667424, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667425, 'HP:0011343', 'Moderate global developmental delay', 'MP:0014120', 'focal seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667426, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667427, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667428, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667429, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667430, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003470', 'abnormal summary potential', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667431, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667432, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667433, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667434, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001845', 'abnormal inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667435, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667436, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667437, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003490', 'decreased channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667438, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667439, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667440, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004752', 'decreased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667441, 'HP:0011343', 'Moderate global developmental delay', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667442, 'HP:0011343', 'Moderate global developmental delay', 'MP:0014253', 'decreased paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667443, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667444, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002826', 'tonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667445, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003484', 'abnormal channel response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667446, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667447, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005402', 'abnormal action potential', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667448, 'HP:0011343', 'Moderate global developmental delay', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667449, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004811', 'abnormal neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667450, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000921', 'demyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667451, 'HP:0011343', 'Moderate global developmental delay', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667452, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667453, 'HP:0011343', 'Moderate global developmental delay', 'MP:0009358', 'environmentally induced seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667454, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667455, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667456, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667457, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020001', 'decreased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667458, 'HP:0011343', 'Moderate global developmental delay', 'MP:0014254', 'increased paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667459, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667460, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003488', 'decreased channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667461, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667462, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667463, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005645', 'abnormal hypothalamus physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667464, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001496', 'audiogenic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667465, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667466, 'HP:0011343', 'Moderate global developmental delay', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667467, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667468, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667469, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667470, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667471, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667472, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667473, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667474, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667475, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667476, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667477, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667478, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667479, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667480, 'HP:0011343', 'Moderate global developmental delay', 'MP:0013438', 'dysmyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667481, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667482, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667483, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667484, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667485, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667486, 'HP:0011343', 'Moderate global developmental delay', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667487, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667488, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003088', 'abnormal prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667489, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667490, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012502', 'decreased hindbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667491, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667492, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667493, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667494, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667495, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667496, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011994', 'increased nerve conduction velocity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667497, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667498, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667499, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667500, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004513', 'avnosmia', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667501, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667502, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667503, 'HP:0011343', 'Moderate global developmental delay', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667504, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667505, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003486', 'abnormal channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667506, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667507, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002499', 'chronic inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667508, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667509, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667510, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667511, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667512, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667513, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667514, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006054', 'spinal hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667515, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667516, 'HP:0011343', 'Moderate global developmental delay', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667517, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667518, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667519, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667520, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002578', 'impaired ability to fire action potentials', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667521, 'HP:0011343', 'Moderate global developmental delay', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667522, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003762', 'abnormal immune organ physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667523, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003633', 'abnormal nervous system physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667524, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006082', 'CNS inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667525, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004495', 'decreased synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667526, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005403', 'abnormal nerve conduction', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667527, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667528, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667529, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010050', 'hypermyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667530, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001898', 'abnormal long-term depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667531, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667532, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667533, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667534, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667535, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667536, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667537, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667538, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667539, 'HP:0011343', 'Moderate global developmental delay', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667540, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667541, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667542, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667543, 'HP:0011343', 'Moderate global developmental delay', 'MP:0021009', 'abnormal synaptic physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667544, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667545, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667546, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667547, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001790', 'abnormal immune system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667548, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003471', 'abnormal summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667549, 'HP:0011343', 'Moderate global developmental delay', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667550, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667551, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667552, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667553, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002922', 'decreased post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667554, 'HP:0011343', 'Moderate global developmental delay', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667555, 'HP:0011343', 'Moderate global developmental delay', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667556, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667557, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667558, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001900', 'impaired synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667559, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667560, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667561, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003217', 'increased spike-wave discharge type I', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667562, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667563, 'HP:0011343', 'Moderate global developmental delay', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667564, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667565, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667566, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667567, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010653', 'abnormal Wallerian degeneration', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667568, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667569, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012011', 'febrile seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667570, 'HP:0011343', 'Moderate global developmental delay', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667571, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667572, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004768', 'abnormal axonal transport', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667573, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003997', 'tonic-clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667574, 'HP:0011343', 'Moderate global developmental delay', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667575, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002635', 'reduced sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667576, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667577, 'HP:0011343', 'Moderate global developmental delay', 'MP:0014178', 'increased brain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667578, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005001', 'abnormal clonal deletion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667579, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005005', 'abnormal self tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667580, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667581, 'HP:0011343', 'Moderate global developmental delay', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667582, 'HP:0011343', 'Moderate global developmental delay', 'MP:0009142', 'decreased prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667583, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667584, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006058', 'decreased cerebral infarct size', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667585, 'HP:0011343', 'Moderate global developmental delay', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667586, 'HP:0011343', 'Moderate global developmental delay', 'MP:0014179', 'abnormal blood-retina barrier function', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667587, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020002', 'increased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667588, 'HP:0011343', 'Moderate global developmental delay', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667589, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667590, 'HP:0011343', 'Moderate global developmental delay', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667591, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002498', 'abnormal acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667592, 'HP:0011343', 'Moderate global developmental delay', 'MP:0000947', 'convulsive seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667593, 'HP:0011343', 'Moderate global developmental delay', 'MP:0013806', 'encephalopathy', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667594, 'HP:0011343', 'Moderate global developmental delay', 'MP:0013182', 'increased spinal cord apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667595, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002906', 'increased susceptibility to pharmacologically induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667596, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002917', 'decreased synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667597, 'HP:0011343', 'Moderate global developmental delay', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667598, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667599, 'HP:0011343', 'Moderate global developmental delay', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667600, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667601, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667602, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667603, 'HP:0011343', 'Moderate global developmental delay', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667604, 'HP:0011343', 'Moderate global developmental delay', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667605, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667606, 'HP:0011343', 'Moderate global developmental delay', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667607, 'HP:0011343', 'Moderate global developmental delay', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667608, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667609, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667610, 'HP:0011343', 'Moderate global developmental delay', 'MP:0003482', 'increased nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667611, 'HP:0011343', 'Moderate global developmental delay', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667612, 'HP:0011343', 'Moderate global developmental delay', 'MP:0021010', 'impaired synaptic physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667613, 'HP:0034392', 'Joint contracture', 'MP:0003198', 'calcified tendon', 0.4444444444444444, 10.799792345853671, 2.1908691675379197, 'UPHENO:0021425', 'abnormal tendon morphology'),
(667614, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0013730', 'glutathionuria', 0.5060240963855421, 11.226325483970346, 2.3834410436920983, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667615, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0011470', 'increased urine creatinine level', 0.4342105263157895, 11.094077685671904, 2.1948041623078476, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(667616, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0020400', 'cystinuria', 0.5454545454545454, 11.226325483970346, 2.474560620389774, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667617, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0003311', 'aminoaciduria', 0.547945205479452, 11.226325483970346, 2.4802038674458475, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667618, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0020406', 'hyperthreoninuria', 0.5061728395061729, 11.226325483970346, 2.383791317930699, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667619, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0011516', 'aspartylglucosaminuria', 0.5405405405405406, 11.226325483970346, 2.4633887320902836, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667620, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0020402', 'ornithinuria', 0.5185185185185185, 11.226325483970346, 2.4126868131514696, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667621, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0011654', 'histidinuria', 0.5256410256410257, 11.226325483970346, 2.4292009471375886, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667622, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0030614', 'methylmalonic aciduria', 0.4074074074074074, 10.47786425096631, 2.066097652496837, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(667623, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0030613', 'dicarboxylic aciduria', 0.4383561643835616, 10.47786425096631, 2.143137042744871, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(667624, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0020401', 'argininuria', 0.5061728395061729, 11.226325483970346, 2.383791317930699, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667625, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0020405', 'taurinuria', 0.5061728395061729, 11.226325483970346, 2.383791317930699, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667626, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0020403', 'lysinuria', 0.4939759036144578, 11.226325483970346, 2.3548958098426067, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667627, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0030689', 'cystathioninuria', 0.5185185185185185, 11.226325483970346, 2.4126868131514696, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667628, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0030618', 'tryptophanuria', 0.5256410256410257, 11.226325483970346, 2.4292009471375886, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667629, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.5185185185185185, 11.226325483970346, 2.4126868131514696, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667630, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0011765', 'oroticaciduria', 0.4794520547945205, 10.47786425096631, 2.241346368811355, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(667631, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0030632', 'increased urine creatine level', 0.41975308641975306, 11.094077685671904, 2.1579558265963863, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(667632, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0020404', 'prolinuria', 0.5061728395061729, 11.226325483970346, 2.383791317930699, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667633, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0030616', 'hyperglycinuria', 0.4880952380952381, 11.226325483970346, 2.3408366047277083, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667634, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0030615', 'ethylmalonic aciduria', 0.4024390243902439, 10.47786425096631, 2.0534608510639534, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(667635, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0002931', 'glutaricadicuria', 0.4024390243902439, 10.47786425096631, 2.0534608510639534, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(667636, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0030620', 'valinuria', 0.4939759036144578, 11.226325483970346, 2.3548958098426067, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667637, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0030617', 'hyperglutaminuria', 0.5061728395061729, 11.226325483970346, 2.383791317930699, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667638, 'HP:0410313', 'Abnormal urinary 1-methylhistidine concentration', 'MP:0030682', 'hydroxyprolinuria', 0.5121951219512195, 11.226325483970346, 2.397930180452774, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667639, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0000020', 'scaly ears', 0.4090909090909091, 10.255471829629862, 2.048272514569165, 'UPHENO:0086699', 'abnormal external ear morphology'),
(667640, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0030071', 'abnormal face shape', 0.425531914893617, 6.5236679405794336, 1.6661419239923307, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(667641, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0020290', 'floppy ears', 0.4090909090909091, 10.255471829629862, 2.048272514569165, 'UPHENO:0086699', 'abnormal external ear morphology'),
(667642, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0000053', 'excessive ear growth', 0.42, 10.255471829629862, 2.0754031339584467, 'UPHENO:0086699', 'abnormal external ear morphology'),
(667643, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0003715', 'posteriorly rotated ears', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(667644, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0003737', 'ossification of pinnae', 0.4090909090909091, 10.255471829629862, 2.048272514569165, 'UPHENO:0086699', 'abnormal external ear morphology'),
(667645, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0009578', 'otocephaly', 0.45454545454545453, 6.5236679405794336, 1.7220056937636088, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(667646, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0000022', 'abnormal ear shape', 0.5681818181818182, 11.115294171581601, 2.5130674587115642, 'UPHENO:0005986', 'abnormal shape of external ear'),
(667647, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0030368', 'trigonocephaly', 0.40816326530612246, 6.5236679405794336, 1.6317847923055813, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(667648, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0003713', 'abnormal ear rotation', 0.4117647058823529, 10.255471829629862, 2.0549553137750456, 'UPHENO:0086699', 'abnormal external ear morphology'),
(667649, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0000018', 'small ears', 0.4375, 10.255471829629862, 2.118199453654699, 'UPHENO:0086699', 'abnormal external ear morphology'),
(667650, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0000023', 'abnormal ear position', 0.40425531914893614, 10.255471829629862, 2.036130898913413, 'UPHENO:0086699', 'abnormal external ear morphology'),
(667651, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0003736', 'folded helix', 0.45454545454545453, 11.115294171581601, 2.2477558678886815, 'UPHENO:0005986', 'abnormal shape of external ear'),
(667652, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0003716', 'anteriorly rotated ears', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(667653, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0002177', 'abnormal outer ear morphology', 0.4186046511627907, 10.255471829629862, 2.0719527522972223, 'UPHENO:0086699', 'abnormal external ear morphology'),
(667654, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0030045', 'abnormal forehead shape', 0.40816326530612246, 6.5236679405794336, 1.6317847923055813, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(667655, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0006290', 'proboscis', 0.45454545454545453, 6.5236679405794336, 1.7220056937636088, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(667656, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0003735', 'cup-shaped ears', 0.5, 11.115294171581601, 2.3574662427680275, 'UPHENO:0005986', 'abnormal shape of external ear'),
(667657, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0000017', 'big ears', 0.4375, 10.255471829629862, 2.118199453654699, 'UPHENO:0086699', 'abnormal external ear morphology'),
(667658, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0030074', 'coarse facial features', 0.4166666666666667, 6.5236679405794336, 1.6486949309200385, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(667659, 'HP:0009912', 'Abnormal tragus morphology', 'MP:0011495', 'abnormal head shape', 0.46511627906976744, 6.5236679405794336, 1.7419139354196116, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(667660, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0011654', 'histidinuria', 0.5333333333333333, 11.226325483970346, 2.44691103055482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667661, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0030615', 'ethylmalonic aciduria', 0.4050632911392405, 10.47786425096631, 2.060145183623379, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(667662, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0011765', 'oroticaciduria', 0.4857142857142857, 10.47786425096631, 2.255936246986902, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(667663, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0020405', 'taurinuria', 0.5128205128205128, 11.226325483970346, 2.3993936716970112, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667664, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0020402', 'ornithinuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667665, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0003311', 'aminoaciduria', 0.5797101449275363, 11.226325483970346, 2.5510810989296564, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667666, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0030616', 'hyperglycinuria', 0.5316455696202531, 12.982656403003482, 2.627198461966437, 'UPHENO:0080641', 'increased level of proteinogenic amino acid in urine'),
(667667, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0020403', 'lysinuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667668, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0030632', 'increased urine creatine level', 0.4050632911392405, 11.094077685671904, 2.1198593395583276, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(667669, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0030617', 'hyperglutaminuria', 0.5128205128205128, 11.226325483970346, 2.3993936716970112, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667670, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0030613', 'dicarboxylic aciduria', 0.463768115942029, 10.47786425096631, 2.204381855025799, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(667671, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0013730', 'glutathionuria', 0.49382716049382713, 11.226325483970346, 2.354541236956483, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667672, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0030620', 'valinuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667673, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0020401', 'argininuria', 0.5128205128205128, 11.226325483970346, 2.3993936716970112, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667674, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0011470', 'increased urine creatinine level', 0.4383561643835616, 11.094077685671904, 2.205256751869132, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(667675, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0020400', 'cystinuria', 0.5333333333333333, 11.226325483970346, 2.44691103055482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667676, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0020404', 'prolinuria', 0.5128205128205128, 11.226325483970346, 2.3993936716970112, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667677, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0011517', 'hyperoxaluria', 0.42105263157894735, 10.47786425096631, 2.1004124157403803, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(667678, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0030689', 'cystathioninuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667679, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0002931', 'glutaricadicuria', 0.4050632911392405, 10.47786425096631, 2.060145183623379, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(667680, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0030614', 'methylmalonic aciduria', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(667681, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0030682', 'hydroxyprolinuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667682, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0030618', 'tryptophanuria', 0.5333333333333333, 11.226325483970346, 2.44691103055482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667683, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667684, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0011516', 'aspartylglucosaminuria', 0.5714285714285714, 11.226325483970346, 2.532793543441182, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667685, 'HP:0033100', 'Increased proteinogenic amino acid level in urine', 'MP:0020406', 'hyperthreoninuria', 0.5128205128205128, 11.226325483970346, 2.3993936716970112, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(667686, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0009827', 'skin detachment', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667687, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0002897', 'blotchy skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667688, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0001213', 'abnormal skin cell number', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667689, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0005421', 'loose skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667690, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0001198', 'tight skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667691, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0012078', 'abnormal tail ring morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667692, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0001208', 'blistering', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667693, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0001212', 'skin lesions', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667694, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0003717', 'pallor', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667695, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0005501', 'abnormal skin physiology', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(667696, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0011515', 'purpura', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667697, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0011239', 'abnormal skin coloration', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(667698, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667699, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0009441', 'delayed skin barrier formation', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667700, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0001191', 'abnormal skin condition', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(667701, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0001216', 'abnormal epidermal layer morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667702, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0008854', 'bleb', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667703, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0002060', 'abnormal skin morphology', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(667704, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0001196', 'shiny skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667705, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0031103', 'skin rash', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667706, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0009563', 'dyskeratosis', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(667707, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0003941', 'abnormal skin development', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(667708, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0009931', 'abnormal skin appearance', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(667709, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0005275', 'abnormal skin tensile strength', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667710, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0009473', 'abnormal skin exfoliation', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667711, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0001192', 'scaly skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667712, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0001195', 'flaky skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667713, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0001243', 'abnormal dermal layer morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667714, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0010071', 'abnormal pruritus', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667715, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0003652', 'abnormal skin turgor', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667716, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0001201', 'translucent skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667717, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0003853', 'dry skin', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667718, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0001193', 'psoriasis', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667719, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0008856', 'fetal bleb', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667720, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0001210', 'skin ridges', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667721, 'HP:0031549', 'Lymphocytoma cutis', 'MP:0008816', 'petechiae', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(667722, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0003477', 'abnormal nerve fiber response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667723, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667724, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0003470', 'abnormal summary potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667725, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0003463', 'abnormal single cell response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667726, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0005402', 'abnormal action potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667727, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0003633', 'abnormal nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667728, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0008814', 'decreased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667729, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667730, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0012006', 'abnormal hippocampus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667731, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0003464', 'abnormal single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667732, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0006080', 'brain ischemia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667733, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667734, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0003467', 'abnormal single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667735, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667736, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0004994', 'abnormal brain wave pattern', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667737, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667738, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0002064', 'seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667739, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667740, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667741, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667742, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667743, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0003471', 'abnormal summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667744, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667745, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0013806', 'encephalopathy', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667746, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0011994', 'increased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667747, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667748, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0003474', 'abnormal summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667749, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0002635', 'reduced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667750, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667751, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0002634', 'abnormal sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667752, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0002578', 'impaired ability to fire action potentials', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667753, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0003889', 'enhanced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667754, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667755, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0005403', 'abnormal nerve conduction', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667756, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0021015', 'increased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667757, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667758, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667759, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667760, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667761, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0003880', 'abnormal central pattern generator function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667762, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667763, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667764, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667765, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667766, 'HP:0032914', 'Focal aware perseverative automatism seizure', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(667767, 'HP:0004365', 'Abnormal circulating tryptophan concentration', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(667768, 'HP:0004365', 'Abnormal circulating tryptophan concentration', 'MP:0005311', 'abnormal circulating amino acid level', 0.4098360655737705, 9.920646740728058, 2.016392528295827, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(667769, 'HP:0008297', 'Transient hyperphenylalaninemia', 'MP:0005311', 'abnormal circulating amino acid level', 0.4032258064516129, 9.920646740728058, 2.000065194575326, 'UPHENO:0051854', 'abnormal blood amino acid level'),
(667770, 'HP:0011234', 'Absent antihelix', 'MP:0003678', 'absent ear lobes', 0.45614035087719296, 10.48475063655155, 2.1868968503833224, 'UPHENO:0026984', 'absent anatomical entity in the ear'),
(667771, 'HP:0011234', 'Absent antihelix', 'MP:0006285', 'absent inner ear', 0.42857142857142855, 10.48475063655155, 2.119779365528897, 'UPHENO:0026984', 'absent anatomical entity in the ear'),
(667772, 'HP:0011234', 'Absent antihelix', 'MP:0003142', 'anotia', 0.4406779661016949, 10.48475063655155, 2.1495112434223245, 'UPHENO:0026984', 'absent anatomical entity in the ear'),
(667773, 'HP:0011234', 'Absent antihelix', 'MP:0005579', 'absent outer ear', 0.4642857142857143, 10.48475063655155, 2.206336315795698, 'UPHENO:0026984', 'absent anatomical entity in the ear'),
(667774, 'HP:0011234', 'Absent antihelix', 'MP:0003735', 'cup-shaped ears', 0.423728813559322, 11.115294171581601, 2.170223585644373, 'UPHENO:0005986', 'abnormal shape of external ear'),
(667775, 'HP:0011234', 'Absent antihelix', 'MP:0000022', 'abnormal ear shape', 0.4716981132075472, 11.115294171581601, 2.2897736325850833, 'UPHENO:0005986', 'abnormal shape of external ear'),
(667776, 'HP:0011234', 'Absent antihelix', 'MP:0030155', 'absent tympanic cavity', 0.4067796610169492, 10.48475063655155, 2.0651836019549643, 'UPHENO:0026984', 'absent anatomical entity in the ear'),
(667777, 'HP:0011234', 'Absent antihelix', 'MP:0009707', 'absent external auditory canal', 0.45614035087719296, 10.48475063655155, 2.1868968503833224, 'UPHENO:0026984', 'absent anatomical entity in the ear'),
(667778, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0030048', 'sloping forehead', 0.41509433962264153, 6.5236679405794336, 1.6455812455519228, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(667779, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0006290', 'proboscis', 0.425531914893617, 6.5236679405794336, 1.6661419239923307, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(667780, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0030074', 'coarse facial features', 0.5434782608695652, 12.700256672302759, 2.6272254202599736, 'UPHENO:0005983', 'abnormal shape of face'),
(667781, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0030072', 'round face', 0.4716981132075472, 12.700256672302759, 2.447588018759851, 'UPHENO:0005983', 'abnormal shape of face'),
(667782, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0008798', 'lateral facial cleft', 0.5957446808510638, 13.437222266468964, 2.8293380304697355, 'UPHENO:0041242', 'split face'),
(667783, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0008799', 'oblique facial cleft', 0.5957446808510638, 13.437222266468964, 2.8293380304697355, 'UPHENO:0041242', 'split face'),
(667784, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0012546', 'triangular face', 0.49019607843137253, 12.700256672302759, 2.495118437235933, 'UPHENO:0005983', 'abnormal shape of face'),
(667785, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0030071', 'abnormal face shape', 0.5555555555555556, 12.700256672302759, 2.6562564167036493, 'UPHENO:0005983', 'abnormal shape of face'),
(667786, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0012175', 'flat face', 0.4716981132075472, 12.700256672302759, 2.447588018759851, 'UPHENO:0005983', 'abnormal shape of face'),
(667787, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0008797', 'facial cleft', 0.6086956521739131, 13.437222266468964, 2.859926357599816, 'UPHENO:0041242', 'split face'),
(667788, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0030045', 'abnormal forehead shape', 0.44, 6.5236679405794336, 1.6942295871147306, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(667789, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0030049', 'prominent forehead', 0.4074074074074074, 6.5236679405794336, 1.6302731803161972, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(667790, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0000448', 'pointed snout', 0.4230769230769231, 6.5236679405794336, 1.6613287933085112, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(667791, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0000108', 'midline facial cleft', 0.56, 13.437222266468964, 2.743144996026025, 'UPHENO:0041242', 'split face'),
(667792, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0030099', 'facial asymmetry', 0.46296296296296297, 12.700256672302759, 2.4248192632440517, 'UPHENO:0005983', 'abnormal shape of face'),
(667793, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0011495', 'abnormal head shape', 0.43478260869565216, 6.5236679405794336, 1.684154792609432, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(667794, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0031501', 'abnormal mouth shape', 0.4074074074074074, 6.5236679405794336, 1.6302731803161972, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(667795, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0009578', 'otocephaly', 0.425531914893617, 6.5236679405794336, 1.6661419239923307, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(667796, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0030063', 'abnormal face size', 0.425531914893617, 11.592196926445306, 2.2210019711684574, 'UPHENO:0020809', 'abnormal face morphology'),
(667797, 'HP:0031587', 'Tessier number 30 facial cleft', 'MP:0030073', 'square face', 0.5, 12.700256672302759, 2.519946097866258, 'UPHENO:0005983', 'abnormal shape of face'),
(667798, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667799, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667800, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667801, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667802, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667803, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667804, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667805, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667806, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667807, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667808, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667809, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667810, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667811, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667812, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667813, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667814, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667815, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667816, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667817, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667818, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667819, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667820, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667821, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667822, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667823, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667824, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667825, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667826, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667827, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667828, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667829, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667830, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667831, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667832, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667833, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667834, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667835, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667836, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667837, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667838, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667839, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667840, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667841, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667842, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667843, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667844, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667845, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667846, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667847, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667848, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667849, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667850, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667851, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667852, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667853, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667854, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667855, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667856, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667857, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667858, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667859, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667860, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667861, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667862, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667863, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667864, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667865, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667866, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667867, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667868, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667869, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667870, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667871, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667872, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667873, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667874, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667875, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667876, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667877, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667878, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667879, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667880, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667881, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667882, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667883, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667884, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667885, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667886, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667887, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667888, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667889, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667890, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667891, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667892, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667893, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667894, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667895, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667896, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667897, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667898, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667899, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667900, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667901, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667902, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667903, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667904, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667905, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667906, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667907, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667908, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667909, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667910, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667911, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667912, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667913, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667914, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667915, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667916, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667917, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667918, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667919, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667920, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667921, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667922, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667923, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667924, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667925, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667926, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667927, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667928, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667929, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667930, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667931, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667932, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667933, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667934, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667935, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667936, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667937, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667938, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667939, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667940, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667941, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667942, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667943, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667944, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667945, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667946, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667947, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667948, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667949, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667950, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667951, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667952, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667953, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667954, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667955, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667956, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667957, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667958, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667959, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667960, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667961, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667962, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667963, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667964, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667965, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667966, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667967, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667968, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667969, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667970, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667971, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667972, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667973, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667974, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667975, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667976, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667977, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667978, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667979, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667980, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667981, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667982, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667983, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667984, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667985, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667986, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667987, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667988, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667989, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667990, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667991, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667992, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667993, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667994, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667995, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667996, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(667997, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667998, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(667999, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668000, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668001, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668002, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668003, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668004, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668005, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668006, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668007, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668008, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668009, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668010, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668011, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668012, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668013, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668014, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668015, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668016, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668017, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668018, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668019, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668020, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668021, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668022, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668023, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668024, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668025, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668026, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668027, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668028, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668029, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668030, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668031, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668032, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668033, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668034, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668035, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668036, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668037, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668038, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668039, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668040, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668041, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668042, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668043, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668044, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668045, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668046, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668047, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668048, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668049, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668050, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668051, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668052, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668053, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668054, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668055, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668056, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668057, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668058, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668059, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668060, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668061, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668062, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668063, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668064, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668065, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668066, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668067, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668068, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668069, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668070, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668071, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668072, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668073, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668074, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668075, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668076, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668077, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668078, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668079, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668080, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668081, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668082, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668083, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668084, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668085, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668086, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668087, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668088, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668089, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668090, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668091, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668092, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668093, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668094, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668095, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668096, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668097, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668098, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668099, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668100, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668101, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668102, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(668103, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668104, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(668105, 'HP:0034189', 'Anti-thyroid-stimulating hormone receptor antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
